40-year expertise in designing and manufacturing cutting-edge instrumentation with a passion for meeting customer needs.
Cutting-edge hardware.
Powerful, user-friendly software.
The quality, reliability and innovation that lies behind BioLogic’s product portfolio help shape the future of research and industry projects around the world.
Our close professional proximity with both academic and industrial users helps us understand our clients’ needs and develop solutions that truly make a difference – through a marriage of cutting-edge, reliable, high-performance hardware and innovative, user-friendly software.
A sustained period of growth.
An innovative product portfolio, strong customer service and a reputation for quality and reliability have all helped to contribute to our significant year-over-year growth of +15% since 2000.
+15%
Annual growth since 2000
90%
Exports internationally
30
Designated distributors worldwide
6
Global subsidiaries
From start-up to leading global player.
BioLogic’s corporate history dates back to 1983 when Yves Dupont, a researcher with the CNRS, a national French research organization, set about creating a company to commercialize measurement instruments in the fields of biochemistry, kinetics, and electrophysiology.
Based in the Grenoble area, in the foothills of the French Alps, the company saw a period of sustained but controlled growth before a strategic move to focus on electrochemistry in 1991. A collaboration with two leading researchers, Yves Chabre (Grenoble-Alps University) and Christian Mouget (CNRS), led to an accumulation of know-how and the creation of the MacPile, the world’s first multichannel computer-controlled potentiostat. The MacPile was the precursor to the vast array of potentiostat/galvanostats now available on the market.
Commercially, the 1990s continued to be an important period for rapid-kinetics instruments. This led to the development of the VMP-3 potentiostat/galvanostat, an instrument which has since proven itself as a research “workhorse” in laboratories across the globe.
A strategic shift to focus on energy storage applications in 2007 was the starting point for a period of rapid expansion. From 2007-2016, BioLogic set up six subsidiaries in the USA, India, Singapore, Spain, UK and Germany, and continued to expand its distributor network, in order to ensure that customers get the help they needed, when they needed it.
Launch of BioLogic’s Premium range: Potentiostat/galvanostats that stand out in the marketplace for their high-end analysis capabilities and ultra-fast acquisition speeds.
In 2014 the company launched a range of high-end battery cyclers the BCS-800 series, a portfolio of products targeting high-throughput energy applications.
The company’s success led to a move in 2016 to a new location combining both factory and office space. But as sustained growth continues, in 2022 BioLogic launched a project to extend its headquarters. An additional 1,900 m2 of laboratory and office space will be annexed in 2024, enabling the company to welcome its new employees with the best working conditions.
Discover BioLogic from the inside.
A truly global footprint
BioLogic has built an extensive international network with 6 subsidiaries and 30 exclusive dealers worldwide to manage our global sales (90% of BioLogic sales are exported). BioLogic affords each of these partners a wide degree of autonomy, enabling them to “think global & act local” thereby answering the specific needs of each territory and ensuring customer satisfaction across the globe.